Library — CHDR

Search

Filter

Pharmacokinetics, pharmacodynamics and the pharmacokinetic/ pharmacodynamic relationship of zolpidem in healthy subjects.

de Haas SL, Schoemaker RC, van Gerven JM, Hoever P, Cohen AF, Dingemanse J

Journal of psychopharmacology (Oxford, England), 2010 Oct; 24(11):1619-29

View publication
A randomized study of alglucosidase alfa in late-onset Pompe's disease.

van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, Herson S, Kishnani PS, Laforet P, Lake SL, Lange DJ, Leshner RT, Mayhew JE, Morgan C, Nozaki K, Park DJ, Pestronk A, Rosenbloom B, Skrinar A, van Capelle CI, van der Beek NA, Wa

The New England journal of medicine, 2010 Apr; 362(15):1396-406

View publication
Central nervous system effects of alcohol at a pseudo-steady-state concentration using alcohol clamping in healthy volunteers.

Zoethout RW, Schoemaker RC, Zuurman L, van Pelt H, Dahan A, Cohen AF, van Gerven JM

British journal of clinical pharmacology, 2009 Sep; 68(4):524-34

View publication
Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis.

Piepers S, Veldink JH, de Jong SW, van der Tweel I, van der Pol WL, Uijtendaal EV, Schelhaas HJ, Scheffer H, de Visser M, de Jong JM, Wokke JH, Groeneveld GJ, van den Berg LH

Annals of neurology, 2009 Jul; 66(2):227-34

View publication
The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers.

de Haas SL, Franson KL, Schmitt JA, Cohen AF, Fau JB, Dubruc C, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2009 Jul; 23(6):625-32

View publication
Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study.

Wirtz PW, Verschuuren JJ, van Dijk JG, de Kam ML, Schoemaker RC, van Hasselt JG, Titulaer MJ, Tjaden UR, den Hartigh J, van Gerven JM

Clinical pharmacology and therapeutics, 2009 Jun; 86(1):44-8

View publication
An association study of riluzole serum concentration and survival and disease progression in patients with ALS.

Groeneveld GJ, van Kan HJ, Lie-A-Huen L, Guchelaar HJ, van den Berg LH

Clinical pharmacology and therapeutics, 2008 Apr; 83(5):718-22

View publication
Pharmacokinetics of riluzole: evidence for glucuronidation as a major metabolic pathway not associated with UGT1A1 genotype.

van Kan HJ, van den Berg LH, Groeneveld GJ, van der Straaten RJ, van Vught PW, Lie-A-Huen L, Guchelaar HJ

Biopharmaceutics & drug disposition, 2008 Mar; 29(3):139-44

View publication
Pseudohallucinations after zolpidem intake: a case report.

de Haas S, Dingemanse J, Hoever P, Cohen A, van Gerven J

Journal of clinical psychopharmacology, 2007 Nov; 27(6):728-30

View publication

«
1
2
...
8
9
10
11
12
13
14
...
18
19
»